Introduction Well-differentiated gastric, duodenal, and rectal neuroendocrine neoplasms
(NETs) are rare diseases usually managed by endoscopic treatment. Although several …

Opinion statement Gastroenteropancreatic neuroendocrine neoplasms (GEP NENs)
comprise a heterogeneous group of slow growing tumors arising from the neuroendocrine …

This ENETS guidance paper, developed by a multidisciplinary working group, provides an
update on the previous colorectal guidance paper in a different format. Guided by key …

Recently, research on rectal neuroendocrine tumors (NETs) has increased during the last
few decades. Rectal NETs measuring< 10 mm without atypical features and confined to the …

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are rare tumors derived
from the neuroendocrine cell system, which that have increased in incidence and …

Aims This study aimed to evaluate the safety, efficacy, and long-term outcomes of
endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) for …

BACKGROUND: Endoscopic mucosal resection (EMR) and endoscopic submucosal
dissection (ESD) are surgical methods used for rectal neuroendocrine tumors (NETs) with …

The prevalence of gastrointestinal neuroendocrine tumors (GI-NETs) is increasing, and
despite recent advances in their therapy, it remains inadequate in patients with advanced …

Objective The first choice of treatment for rectal neuroendocrine tumors (R-NETs) 10 mm in
size is endoscopic resection, there is still controversy concerning the optimal endoscopic …

Abstract Introduction Endoscopic Submucosal Dissection (ESD) has been reported as a
feasible and effective treatment for Rectal Neuroendocrine Tumours (R-NETs). However …